Home » Bill Funds Efficacy Comparisons, Limits ESA Reimbursements
Bill Funds Efficacy Comparisons, Limits ESA Reimbursements
August 3, 2007
The House voted 225-204 Aug. 1 to pass H.R. 3162, the Children’s Health and Medicare Protection Act of 2007 (CHAMP Act), which includes a provision gauging the effectiveness of prescription drugs and medical devices, and lowering the reimbursement rates for erythropoietin-stimulating agents (ESAs).